Healthcare (Prescription Drugs)

This bill eliminates a requirement for Vermont's Department of Vermont Health Access to annually compile and share lists of prescription drugs with significant price increases (50%+ over five years or 15%+ in a year). The Department would no longer need to create these lists, which previously included details on cost increases, drug types (generic/brand), and spending data for the Office of the Attorney General and Green Mountain Care Board. The change directly affects the Department's administrative duties under existing prescription drug cost transparency rules. Other provisions in the bill adjust committee memberships, update health insurance market language, and modify Medicaid eligibility and doula service coverage timelines, but the core policy change is removing the annual drug price reporting requirement.